XML 136 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Changes in Temporary Equity and Stockholders' Equity - USD ($)
$ in Millions
Total
Senior A Senior Preferred Shares
Redeemable non- controlling interest
Cumulative 5.5% Dividends on Series A Senior Preferred Shares
Common stock
Additional paid-In capital ("APIC")
Retained earnings
Retained earnings
Senior A Senior Preferred Shares
Retained earnings
Cumulative 5.5% Dividends on Series A Senior Preferred Shares
Accumulated other comprehensive loss
Non- controlling interest ("NCI")
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net income (loss) $ 0.0                    
Balance (in shares) at Dec. 31, 2020         109,876,428            
Balance at Dec. 31, 2020 1,012.4       $ 200.4 $ 49.2 $ 791.9     $ (34.3) $ 5.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) 151.9           151.9        
Other comprehensive (loss) income (21.7)                 (21.7)  
Controlling interests 130.2           151.9     (21.7)  
Stock option exercises (in shares)         495,021            
Stock option exercises 16.2       $ 20.0 (3.8)          
Issuance of common stock related to vesting of share units (in shares)         238,139            
Issuance of common stock related to vesting of share units (9.5)       $ 2.3 (11.8)          
Acquisition of remaining interest in NCI (5.7)         (1.2) 0.1       (4.6)
Issuance of common stock related to business combinations (in shares)         63,971            
Forfeiture of common stock related to business combinations (in shares)         (55,510)            
Forfeiture of common stock related to business combinations (0.1)         (0.1)          
Share-based continuing employment costs related to business combinations 10.9       $ 4.8 6.1          
Share-based payments expense 20.6         20.6          
Equity-classified share units dividend equivalents 0.0         0.5 (0.5)        
Dividends paid to common stockholders (103.9)           (103.8)       (0.1)
Balance (in shares) at Dec. 31, 2021         110,618,049            
Balance at Dec. 31, 2021 1,071.1       $ 227.5 59.5 839.6     (56.0) 0.5
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net income (loss) $ 0.0                    
Temporary equity, ending balance (in shares) at Dec. 31, 2022 0 0                  
Ending balance at Dec. 31, 2022   $ 0.0 $ 0.0                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) $ 319.7           319.7        
Other comprehensive (loss) income (29.1)                 (29.1)  
Controlling interests 290.6           319.7     (29.1)  
Stock option exercises (in shares)         159,920            
Stock option exercises 5.8       $ 7.2 (1.4)          
Issuance of common stock related to vesting of share units (in shares)         103,394            
Issuance of common stock related to vesting of share units (3.8)       $ 3.0 (6.8)          
Share-based continuing employment costs related to business combinations 7.5       $ 8.6 (1.1)          
Share-based payments expense 34.2         34.2          
Equity-classified share units dividend equivalents 0.0         0.9 (0.9)        
Dividends paid to common stockholders $ (115.2)                    
Balance (in shares) at Dec. 31, 2022 110,881,363       110,881,363            
Balance at Dec. 31, 2022 $ 1,290.1       $ 246.3 85.3 1,043.2     (85.1) 0.5
Increase (Decrease) in Temporary Equity [Roll Forward]                      
Net income (loss)     (0.5)                
Net income (loss) $ 0.5   (0.5)                
NCI acquired in business combination     8.9                
Issuance of Series A Senior Preferred Shares and common stock, net of issuance costs (in shares)   485,000,000                  
Issuance of Series A Senior Preferred Shares and common stock, net of issuance costs   $ 482.0                  
Temporary equity, ending balance (in shares) at Dec. 31, 2023 485,000,000 485,000,000                  
Ending balance at Dec. 31, 2023   $ 482.0 $ 8.4                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income (loss) $ 206.5           206.5        
Other comprehensive (loss) income 41.1                 41.1  
Controlling interests 247.6           206.5     41.1  
Stock option exercises (in shares)         723,443            
Stock option exercises 34.5       $ 42.9 (8.4)          
Issuance of common stock related to vesting of share units (in shares)         467,747            
Issuance of common stock related to vesting of share units (19.0)       $ 17.4 (36.4)          
Issuance of common stock related to ESPP purchase (in shares)         180,503            
Issuance of common stock related to ESPP 9.2       $ 11.4 (2.2)          
Issuance of common stock related to business combination (in shares)         70,339,723            
Issuance of common stock related to business combination 3,712.9       $ 3,712.9            
Share-based continuing employment costs related to business combinations 3.0       $ 8.3 (5.3)          
Replacement of share-based awards in business combination 13.1         13.1          
Share-based payments expense 40.3         40.3          
Equity-classified share units dividend equivalents 0.0         1.6 (1.6)        
NCI acquired in business combination 1.8                   1.8
Issuance of Series A Senior Preferred Shares and common stock, net of issuance costs (in shares)         251,163            
Issuance of Series A Senior Preferred Shares and common stock, net of issuance costs 15.0       $ 15.0            
Participating dividends on Series A Senior Preferred Shares   $ (7.3)   $ (24.3)       $ (7.3) $ (24.3)    
Dividends paid to common stockholders $ (298.0)                    
Balance (in shares) at Dec. 31, 2023 182,843,942       182,843,942            
Balance at Dec. 31, 2023 $ 5,019.0       $ 4,054.2 $ 88.0 $ 918.5     $ (44.0) $ 2.3